NASDAQ:NEPTNeptune Wellness Solutions Stock Price, Forecast & News

Neptune Wellness Solutions' stock was trading at $1.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NEPT stock has increased by 160.3% and is now trading at $3.15. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Neptune Wellness Solutions.

Neptune Wellness Solutions is scheduled to release its next quarterly earnings announcement on Wednesday, June 10th 2020. View our earnings forecast for Neptune Wellness Solutions.

Neptune Wellness Solutions Inc (NASDAQ:NEPT) announced its quarterly earnings data on Wednesday, October, 12th. The biotechnology company reported ($0.02) earnings per share for the quarter. The biotechnology company earned $8.91 million during the quarter. Neptune Wellness Solutions had a negative net margin of 132.09% and a negative return on equity of 39.22%. View Neptune Wellness Solutions' earnings history.

Neptune Wellness Solutions updated its first quarter 2021 IntraDay earnings guidance on Thursday, May, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $18-22 million.

3 brokers have issued 1 year target prices for Neptune Wellness Solutions' stock. Their forecasts range from $3.75 to $3.75. On average, they expect Neptune Wellness Solutions' stock price to reach $3.75 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price. View analysts' price targets for Neptune Wellness Solutions.

News headlines about NEPT stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Neptune Wellness Solutions earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutNeptune Wellness Solutions.

Neptune Wellness Solutions saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 8,430,000 shares, an increase of 14.1% from the April 30th total of 7,390,000 shares. Based on an average daily trading volume, of 1,310,000 shares, the days-to-cover ratio is presently 6.4 days. Approximately 11.0% of the shares of the stock are sold short. View Neptune Wellness Solutions' Current Options Chain.

Some companies that are related to Neptune Wellness Solutions include Odonate Therapeutics (ODT), MacroGenics (MGNX), Phibro Animal Health (PAHC), Rocket Pharmaceuticals (RCKT), Passage Bio (ORIC), Enanta Pharmaceuticals (ENTA), Applied Therapeutics (APLT), Athenex (ATNX), BioXcel Therapeutics (BTAI), INDIVIOR PLC/S (INVVY), ImmunoGen (IMGN), Rhythm Pharmaceuticals (RYTM), Cue Biopharma (CUE), Amphastar Pharmaceuticals (AMPH) and Stoke Therapeutics (STOK). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), Amarin (AMRN), Zynerba Pharmaceuticals (ZYNE), Aphria (APHA), Cara Therapeutics (CARA), Crispr Therapeutics (CRSP) and Sangamo Therapeutics (SGMO).

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Neptune Wellness Solutions' stock is owned by many different institutional and retail investors. Top institutional investors include AdvisorShares Investments LLC (0.42%), Deutsche Bank AG (0.24%), White Pine Capital LLC (0.12%) and Two Sigma Investments LP (0.06%).

NEPT stock was purchased by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Two Sigma Investments LP, White Pine Capital LLC, and AdvisorShares Investments LLC.

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NEPT stock can currently be purchased for approximately $3.15.

Neptune Wellness Solutions has a market capitalization of $299.44 million and generates $18.39 million in revenue each year. The biotechnology company earns $-17,670,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.

The official website for Neptune Wellness Solutions is www.neptunecorp.com.

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]